Bristol-Myers Squibb (BMY) Declares $0.45 Quarterly Dividend; 3.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bristol-Myers Squibb (BMY) Confirms JCAR017 Plants Have Been Inspected by FDA - Bloomberg
September 8, 2020 3:43 PM EDTBristol-Myers Squibb (NYSE: BMY) Confirms JCAR017 Plants Have Been Inspected by FDA - Bloomberg
Bristol-Myers Squibb CVR Sinks on FDA Manufacturing Plant Inspections - Mizuho
September 8, 2020 1:17 PM EDTBristol-Myers Squibb CVR (NYSE: BMY-R) is trading down 20%. Mizuho analyst Salim Syed highlighted that management disclosed the FDA has communicated to BMY that both the JCAR017 manufacturing facility in Bothell, WA and vector CMO facility in Texas will require inspection.
The analyst... More
Bristol-Myers Squibb (BMY) Research at ESMO Virtual Congress 2020 Highlights Significant Progress in Cancers with High Unmet Medical Need
September 8, 2020 7:00 AM EDTBristol Myers Squibb (NYSE: BMY) today announced the presentation of research spanning 15 different cancers at the upcoming European Society for Medical Oncology (ESMO) Virtual Congress 2020, reinforcing the depth and breadth of its oncology development program, leadership in immuno-oncology and commitment to delivering value to patients and health systems by discovering potential options to improve long-term outcomes in... More
